Li, Y., Dai, C., Yang, H., Zeng, H., Ruan, Y., Dai, M., . . . Ji, F. (2024). Cross‐sectional and Mendelian randomization study of fibroblast growth factor 19 reveals causal associations with metabolic diseases. Journal of gastroenterology and hepatology, 39(12), 2872-2879. https://doi.org/10.1111/jgh.16687
Citace podle Chicago (17th ed.)Li, Yan, et al. "Cross‐sectional and Mendelian Randomization Study of Fibroblast Growth Factor 19 Reveals Causal Associations with Metabolic Diseases." Journal of Gastroenterology and Hepatology 39, no. 12 (2024): 2872-2879. https://doi.org/10.1111/jgh.16687.
Citace podle MLA (9th ed.)Li, Yan, et al. "Cross‐sectional and Mendelian Randomization Study of Fibroblast Growth Factor 19 Reveals Causal Associations with Metabolic Diseases." Journal of Gastroenterology and Hepatology, vol. 39, no. 12, 2024, pp. 2872-2879, https://doi.org/10.1111/jgh.16687.